Header links
Intranet
Donate now
image/svg+xml Map
Contact us

A 2-Part, Randomized, Double-Blind, Placebo-Controlled Study in Participants with Duchenne Muscular Dystrophy Amenable to Exon 45 Skipping with an Initial Multiple Ascending Dose Part A to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ENTR-601-45, Followed by Part B to Evaluate the Safety and Efficacy of ENTR-601-45 (ELEVATE-45)

Contact

Contact Form

I have read and accept the data protection policy *.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Controller: Fundació Hospital Universitari Vall Hebron Institut de Recerca – VHIR- G60594009.
Purpose: Request for information on VHIR clinical research.
Legitimation: Your consent. The data requested is necessary and your request cannot be processed if you do not provide them.
Transfers: Your data will not be transferred to third parties except to the Principal Investigator who leads the research in order to be able to respond to your query.
Data retention time: As long as they are useful for the purpose for which they were collected and responsibilities may arise.
Rights: You can access, rectify, delete your data, oppose or limit its processing and request its portability, as well as revoke your consent without retroactive effects by contacting lopd@vhir.org. The revocation of consent and the opposition to the processing of your data will prevent the purpose from being carried out. DPO: dpd@ticsalutsocial.org. More information 
The request for information on a research project or clinical trial does not entail inclusion in it.

AFFIRM: A Randomized, double-blind, placebo-controlled, study to evaluate the effect of Seladelpar on clinical outcomes in patients with primary biliary cholangitis (PBC) and compensated cirrhosis.

Contact
  • Protocol code: CB8025-41837
  • EudraCT code: 2024-516525-31
  • Pathology: Símptomes, signes i troballes anormals clíniques i de laboratori, no classificades enlloc més
  • Principal investigator:  Villagrasa Vilella, Ares Aurora
  • Research group:  Malalties hepàtiques
  • Service: Hepatologia
  • Phase: Fase III
  • Recruiting: Closed
  • Status: Iniciat

Contact Form

I have read and accept the data protection policy *.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Controller: Fundació Hospital Universitari Vall Hebron Institut de Recerca – VHIR- G60594009.
Purpose: Request for information on VHIR clinical research.
Legitimation: Your consent. The data requested is necessary and your request cannot be processed if you do not provide them.
Transfers: Your data will not be transferred to third parties except to the Principal Investigator who leads the research in order to be able to respond to your query.
Data retention time: As long as they are useful for the purpose for which they were collected and responsibilities may arise.
Rights: You can access, rectify, delete your data, oppose or limit its processing and request its portability, as well as revoke your consent without retroactive effects by contacting lopd@vhir.org. The revocation of consent and the opposition to the processing of your data will prevent the purpose from being carried out. DPO: dpd@ticsalutsocial.org. More information 
The request for information on a research project or clinical trial does not entail inclusion in it.
09/10/2025

Doctoral thesis Respiratory complications following SARS-CoV-2 infection
Ubicació
Boardroom of the VHIR Edifici Central (Floor 0)
Etiqueta
Tesis
19/09/2025

Tesis doctoral Asthma due to exposure to allergens and other environmental pollutants: inflammatory and immunologic response
Ubicació
Sala d'actes de l'Edifici Central del VHIR (Planta 0)
Etiqueta
Tesis

Institutional projects

09/09/2025

Vall d'Hebron Talks by VHIR 'Sepsis Code Update: Where We Are and Where We Are Heading'
Ubicació
Sala d’actes de la planta baixa de l’Hospital General
Etiqueta
Vall d'Hebron Talks by VHIR
15/10/2025

Vall d'Hebron Talks by VHIR 'Targeting of monocytes and tumor-associated macrophages in cancer: lessons and perspectives'
Ubicació
Boardroom of the VHIR Edifici Central (Floor 0)
Etiqueta
Vall d'Hebron Talks by VHIR
23/09/2025

Conferència inaugural dels Màsters VHIR "The future is here to stay: gene, cell and gene-editing therapies in rare diseases" a càrrec de la Dra. Gemma Marfany
Ubicació
Sala d'actes de l'Edifici Central del VHIR (Planta 0)
Etiqueta
Jornades
11/07/2025

Graduació Curs Acadèmic 2024-2025- Màster en Investigació Biomèdica Traslacional - Màster en Gestió i Coordinació en assaigs clínics - Vall d'Hebron Institut de Recerca (VHIR)
Ubicació
Sala d’actes de la planta 1 del Pavelló Docent
Etiqueta
Jornades
06/10/2025

The Lean Event 2025: Lean Day Global i Lean Day Sanitat
Ubicació
Sala d’actes de la planta 1 del Pavelló Docent
Etiqueta
Jornades
Subscribe to